KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Dividends Paid - Common: 2009-2018

Historic Dividends Paid - Common for Teva Pharmaceutical Industries (TEVA) over the last 8 years, with Mar 2018 value amounting to $12.0 million.

  • Teva Pharmaceutical Industries' Dividends Paid - Common fell 96.53% to $12.0 million in Q1 2018 from the same period last year, while for Mar 2018 it was $567.0 million, marking a year-over-year decrease of 68.34%. This contributed to the annual value of $52.0 million for FY2019, which is 333.33% up from last year.
  • Teva Pharmaceutical Industries' Dividends Paid - Common amounted to $12.0 million in Q1 2018, which was down 86.21% from $87.0 million recorded in Q4 2017.
  • In the past 5 years, Teva Pharmaceutical Industries' Dividends Paid - Common registered a high of $2.0 billion during Q4 2014, and its lowest value of -$299.0 million during Q2 2014.
  • Moreover, its 2-year median value for Dividends Paid - Common was $123.0 million (2017), whereas its average is $182.6 million.
  • Its Dividends Paid - Common has fluctuated over the past 5 years, first climbed by 7.26% in 2014, then plummeted by 96.53% in 2018.
  • Quarterly analysis of 4 years shows Teva Pharmaceutical Industries' Dividends Paid - Common stood at $2.0 billion in 2014, then declined by 0.98% to $2.0 billion in 2015, then reached $87.0 million in 2017, then tumbled by 96.53% to $12.0 million in 2018.
  • Its Dividends Paid - Common was $12.0 million in Q1 2018, compared to $87.0 million in Q4 2017 and $123.0 million in Q3 2017.